Coronavirus: why combining the Oxford vaccine with Russia’s Sputnik V vaccine could make it more effective
COVID-19 model reveals key role for innate immunity in controlling viral load
21 January 2021Kenya says it has detected S. Africa COVID-19 strain
21 January 2021Coronavirus: why combining the Oxford vaccine with Russia’s Sputnik V vaccine could make it more effective
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of the vaccine at stopping people developing symptomatic COVID-19, two weeks after the second dose, was 70%. But this wasn’t the whole picture.
